Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: rural

Two people sitting on a grassy hill.

Getting to Know the New Foundation President

Gretchen Henkel  |  December 9, 2023

Liana Fraenkel, MD, MPH, credits much of her own career success to support from the Foundation, and she is eager to advance its mission during her presidency.

Filed under:Profiles Tagged with:Rheumatology Research Foundation

Rheum in the Court, Law in the Clinic: Health Policy in Global Rheumatology

Glen Rodman  |  December 6, 2023

SAN DIEGO—At ACR Convergence 2023, panelists presented information concerning several policy issues that affect rheumatologists & their patients, including abortion access & the WHO’s Essential Medicine List.

Filed under:ACR ConvergenceConditionsGuidanceLegislation & AdvocacyLegislation & AdvocacyMeeting ReportsMeeting ReportsPediatric ConditionsProfessional Topics Tagged with:ACR Convergence 2023Juvenile Arthritis (JIA)reproductive rights

Rheum in the Court, Law in the Clinic: Health Policy in Global Rheumatology

Glen Rodman  |  December 5, 2023

At ACR Convergence 2023, panelists presented information concerning several policy issues that affect rheumatologists & their patients, including abortion access & the WHO’s Essential Medicine List.

Filed under:ACR ConvergenceConditionsGuidanceLegislation & AdvocacyLegislation & AdvocacyMeeting ReportsMeeting ReportsPediatric ConditionsProfessional Topics Tagged with:abortionACR Convergence 2023Juvenile Arthritis (JIA)reproductive rights

The 2023 ACR Awards of Distinction

Patrice Fusillo  |  November 13, 2023

SAN DIEGO—During ACR Convergence 2023 on Nov. 11, the ACR honored a group of individuals who have made significant contributions to rheumatology research, education and patient care by announcing the recipients of the ACR’s 2023 Awards of Distinction, as well as the 2023 ACR Masters who were recognized for their contributions to the field.

Filed under:ACR ConvergenceAwardsCareerMeeting Reports Tagged with:ACR Convergence 2023

Pakistani-Native Dr. Iman Qaiser Serves Choctaw Nation in Oklahoma

Elizabeth Hofheinz, MPH, MEd  |  November 10, 2023

Some people may think Pakistan and Oklahoma share little in common, but one recent graduate of the rheumatology fellowship program at Louisiana State University, Shreveport (LSUS), School of Medicine disagrees. Iman Qaiser, MD, MBBS, a native of Pakistan who is starting a role as the only rheumatologist serving the Choctaw Nation of Oklahoma, sees natural…

Filed under:ProfilesWorkforce Tagged with:Dr. Iman Qaiser

U.S. Supreme Court Ruling Potentially Dampens Diversity

Vanessa Caceres  |  October 9, 2023

Rheumatologists consider ways to encourage racial and ethnic diversity among students and in the workforce in the aftermath of the Supreme Court’s ruling that ends affirmative action in higher education.

Filed under:Legislation & AdvocacyWorkforce Tagged with:DiversityWorkforce

Ignite the Spark of Joy & Discovery

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  September 9, 2023

A Roshi (i.e., master) apparently said that in Zen, “there is nothing to believe and everything to discover.” Interestingly enough, I have never been able to confirm who actually said that, which makes this saying about belief and discovery particularly apt. Regardless, I think about those words at least twice a day when I am…

Filed under:Career DevelopmentEducation & TrainingOpinionProfessional TopicsRheuminations

Ethics Forum: Thoughts on Managing Electronic Communication with Patients

James Topilow, MD, & Yvonne M. Golightly, PT, MS, PhD  |  August 14, 2023

Recent proposals in the U.S. to bill for electronic communication with our patients could be seen as a refreshing but contested attempt to battle burnout rates in the present era. A fee for electronic communications between patients and clinicians also acknowledges the value of the clinician’s time and expertise. But is this ethical? Discussion Burnout…

Filed under:Billing/CodingEthicsPractice ManagementProfessional Topics Tagged with:burnoutEquityEthics Forumpatient communicationphysician-patient communicationwellness

FDA Commissioner Charts Potential & Challenges of Emerging Technologies in Patient Care

Ryan Basen  |  June 20, 2023

Disparities, representativeness, algorithmic bias, the disruptive emergence of large language models and continued misinformation spread are key issues poised to transform patient care in American healthcare, FDA Commissioner Robert M. Califf, MD, said during a recent event.

Filed under:Meeting Reports Tagged with:patient engagementRobert M. CaliffTechnologyU.S. Food and Drug Administration (FDA)

Charting a New Course Post-PHE

From the College  |  May 23, 2023

The public health emergency (PHE), in place since 2020, officially expired at midnight on May 11. The PHE declaration allowed significant flexibility in the healthcare system. The end of the PHE impacts several policies, including changes in Medicare and Medicaid policies. What do these changes mean for providers?

Filed under:Practice Support Tagged with:COVID-19telehealthU.S. public health emergency

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 29
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences